Navigation Links
Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting

ctive anti-VEGF, VTA and VEA technologies. These positive developments in our clinical and preclinical programs reinforce our belief that the future for Peregrine has never been brighter, and we look forward to progressing these programs both on our own and with partners and collaborators going forward."

Highlights of seven of Peregrine's AACR presentations this week follow.

Peregrine's Selective Anti-VEGF Antibody Program

Drugs blocking vascular endothelial growth factor (VEGF) are proving very successful as anti-cancer agents, and for the first time researchers presented animal data on Peregrine's anti-VEGF antibodies that selectively block binding to the second of the two VEGF receptors. Current anti-VEGF drugs such as Avastin(R) block binding to both receptors, yet in preclinical studies comparing Peregrine's selective anti-VEGF antibody to Avastin, the selective antibodies compared favorably on all efficacy parameters assessed, inhibiting tumor growth by 90% in preclinical cancer models. Antibodies with greater selectivity may have advantages in clinical use since they have the potential to only inhibit angiogenesis while not impairing other functions of VEGF. Additional data that was presented showing the efficacy of Peregrine's fully human selective anti-VEGF antibody (R3) is expected to help facilitate the progress of this program towards clinical trials.

Broad Applicability and Versatility of Bavituximab, Peregrine's Targeted Anti-PS Antibody

Researchers affiliated with Peregrine presented a number of preclinical studies demonstrating the versatility and broad anti-cancer utility of bavituximab in major cancer models. They also reported data validating bavituximab's unique mechanism of action and supporting potential new applications of Peregrine's anti-PS technology platform. These included:

    *  Data supporting the potential use of bavituximab to enhance immune

       responses to existing tumors and as a po
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
4. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
5. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
11. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/21/2014)... , Aug. 21, 2014  The board of ... a leading provider of clinical trial imaging solutions, today ... named chief financial officer, effective immediately.  Mr. Groff has ... August 2013.  He joined VirtualScopics in January 2006 as ... February 2013. "When the board of VirtualScopics ...
(Date:8/21/2014)... SAN JOSE, Calif. , Aug. 21, 2014 /PRNewswire/ ... a medical device company that pioneered the use of ... surgical (MIS) device indicated for fusion of the sacroiliac ... ) published an update to its Lumbar Fusion ... MIS SI joint fusion procedure.  The policy states that ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 22, 2011 GeNO LLC ( www.genollc.com ), ... announced commencement of  the PHiano Study: A Phase ... Hypertension in patients with Pulmonary Arterial Hypertension (PAH) ... (PH-IPF) using Inhaled NITROSYL™ nitric oxide (NO).  The ...
... March 22, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ...  J. Michael Pearson, currently Valeant,s Chief Executive Officer (CEO), as ... who remains on the Valeant Board as an independent Board ... role as CEO and has agreed to extend his contract ...
Cached Medicine Technology:GeNO LLC Initiates Study of Inhaled NITROSYL™ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients 2GeNO LLC Initiates Study of Inhaled NITROSYL™ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients 3
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about the ... PRP therapy LA specialist has firmly stated that the ... practical well researched science and nothing to do with ... medical breakthrough technology which focuses on healing and repair ... , The Managing Director of one of the top ...
(Date:8/22/2014)... 2014 Teen substance abuse has long ... Unfortunately, most young adults never receive the professional treatment ... community, the new Troubled Teens Columbus helpline was established ... overcome their drug and alcohol dependencies . ... and their parents can speak directly to a representative ...
(Date:8/22/2014)... Aid in Recovery, a full service ... regarding a recent bill introduced in the ... current legislator and retired police general. In House Bill ... offenders, rather than imprisonment. Aid in Recovery points to ... for the drug addiction epidemic. , The bill, introduced ...
(Date:8/21/2014)... August 22, 2014 Yoga Darshana Center, ... Island region, proudly announces the launch of their newest ... the West Babylon-based yoga studio’s new teacher training program, ... become teachers realize their dreams. , Since 2001, Yoga ... living in the surrounding area a place to learn ...
(Date:8/21/2014)... UWDress.com, a well-known wedding dress manufacturer, has added a new ... store. In addition to this, all these beautiful gowns are ... at the moment. The special offer will last from this ... workers have updated its online category with these affordable, elegant ... is a one stop place where worldwide people can buy ...
Breaking Medicine News(10 mins):Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:Yoga Darshana Center Announces Launch of New Website LongIslandYogaTeacherTraining.com 2Health News:Beautiful Peacock Party Dresses for 2014 Offered by UWDress.com at the Moment 2
... China, April 9, 2008 /Xinhua-PRNewswire-FirstCall/ -- China ... or "the Company") (OTC Bulletin,Board: CSKI), a ... pharmaceuticals for external use in the People,s ... announced that it has,closed its acquisition of ...
... 9, 2008 Eurosport Active World, Corp.,(Pink Sheets: ... and,Eagle International Holdings Group, Inc. have completed a ... common stock,trades on the "Pink Sheets" under the ... merged. Subsequent to a 1000:1 reverse stock,split, the ...
... men shouldn,t presume relationship is wanted based on appearance ... -- Young adults can discern another person,s attitude toward ... face, according to a British study of 700 heterosexual ... men generally prefer women who they believe are open ...
... to Grant Call Option to Subscribe for 19.99% New Shares of ... ... China Medical Services Business, HONG KONG, April 9, 2008 /Xinhua-PRNewswire/ ... service groups,in Hong Kong, ("Town Health" or the "Group"; SEHK: 8138) ...
... Create Leading, Full-Service Global Graphic ... Communication Services Organization, NEW ... New York-based private equity firm that invests in middle-market,specialty ... has completed its acquisition of Diversified Global,Graphics Group ("DG3"). ...
... LAKE CITY, April 9, 2008 UCN, Inc.,(Nasdaq: ... center,solutions announced today that a premiere national non-profit,patient-advocacy ... to use the UCN inContact(R) solution across six ... Advocate Foundation performed a thorough search and determined,that ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc. 2Health News:China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc. 3Health News:Faces May Provide Clues to Sexual Attitudes 2Health News:Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area 2Health News:Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area 3Health News:Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area 4Health News:Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area 5Health News:Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area 6Health News:Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area 7Health News:Arsenal Capital Partners Invests in DG3 2Health News:Arsenal Capital Partners Invests in DG3 3Health News:Nation's Premiere Patient Advocate Organization Commits to UCN inContact(R) for Entire Group 2Health News:Nation's Premiere Patient Advocate Organization Commits to UCN inContact(R) for Entire Group 3
... selecting an oxygen conserver, it's important to have ... Now allied, a name synonymous with innovative excellence, ... Liberty™, two totally automatic and value packed conservers., ... Liberty can be used 8 hours a day ...
Proven and Efficient Stand-Alone Device. Offers a choice between alternate breath and every breath delivery. This model provides every breath delivery....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
... ,Offers an average 5:1 increase in usage ... use of a standard cannula. , ,The ... offers ambulatory oxygen patients a superior alternative to ... 2-year warranty. , ...
Medicine Products: